Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Ajanta Pharma has informed about the schedule of Analyst/Institutional Investor Meeting with the Company on 12-August-24. The schedule of the above-mentioned meetings is subject to change and the change may occur due to exigencies on either side. Further confirmed that the discussion during these meetings will be strictly on the basis of already published information and no Unpublished Price Sensitive Information is proposed to be discussed in these meetings.
The above information is a part of company’s filings submitted to BSE.
